Metabolic disease and participant age are independent predictors of response to pulmonary rehabilitation

Journal of Cardiopulmonary Rehabilitation and Prevention

Volumn 33, Issue 4, 2013, Pages 249-256

  Walsh, James R ^a,b   McKeough, Zoe J ^c   Morris, Norman R ^a,d,e   Chang, Angela T ^b   Yerkovich, Stephanie T ^a   Seale, Helen E ^a   Paratz, Jenny D ^b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

^e GRIFFITH UNIVERSITY   (Australia)

Author keywords

6 minute walk distance; comorbidities; COPD; predictive factors; pulmonary rehabilitation

Indexed keywords

ADULT; AGE; AGE DYSPNEA AND AIRFLOW OBSTRUCTION INDEX; AGED; ARTICLE; BODY MASS INDEX AIRFLOW OBSTRUCTION DYSPNEA AND EXERCISE CAPACITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULMONARY REHABILITATION; TREATMENT RESPONSE;

AGE FACTORS; AGED; BODY MASS INDEX; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MOTOR ACTIVITY; PREVALENCE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUEENSLAND; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84880331992     PISSN: 19327501     EISSN: 1932751X     Source Type: Journal    
DOI: 10.1097/HCR.0b013e31829501b7     Document Type: Article

References (40)

1. Donaldson GC, Wedzicha JA. COPD exacerbations.1:Epidemiology. Thorax. 2006;61:164-168.
2. Economic impact of COPD and cost effective solutions:report by Access Economic Pty Limited for the Australian Lung Foundation. http://lungfoundation. com.au/professional-resources/publications/economic-impact-of-copd/. Published 2008. Accessed February 2010.
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020:Global Burden of Disease Study. Lancet. 1997;349 (9064):1498-1504.
4. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173:1390-1413.
5. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation:joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131 (5) (suppl):4S-42S.
6. Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2005;86:1979-1985.
7. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance:change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23:28-33.
8. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease:The updated BODE index and the ADO index. Lancet. 2009;374 (9691):704-711.
9. Landry MD, Hamdan E, Al Mazeedi S, Brooks D. The precarious balance between 'supply' and 'demand' for health care:The increasing global demand for rehabilitation service for individuals living with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3:393-396.
10. Frith P, Alison J, Burdon J, et al. Case statement:Chronic obstructive pulmonary disease (COPD):The Australian Lung Foundation. http://www. lungfoundation.com.au/professional-resources/publications/copd-case-statements- 2001-and-2002/. Published 2001. Accessed May 2012.
11. Brooks D, Sottana R, Bell B, et al. Characterization of pulmonary rehabilitation programs in Canada in 2005. Can Respir J. 2007;14:87-92.
12. Yohannes AM, Connolly MJ. Pulmonary rehabilitation programmes in the UK:A national representative survey. Clin Rehabil. 2004;18:444-449.
13. Vagaggini B, Costa F, Antonelli S, et al. Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respir Med. 2009;103:1224-1230.
14. Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J. 2006;27:788-794.
15. Evans RA, Singh SJ, Collier R, Williams JE, Morgan MDL. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med. 2009;103:1070-1075.
16. Troosters T, Gosselink R, Decramer M. Exercise training in COPD:how to distinguish responders from nonresponders. J Cardiopulm Rehabil. 2001;21:10-17.
17. Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008;63:487-492.
18. Crisafulli E, Gorgone P, Vagaggini B, et al. Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J. 2010;36:1042-1048.
19. Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2010;91:221-225.
20. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status:The Six Minute Walk Test in chronic lung disease patients. Am J Respir Crit Care Med. 1997;155:1278-1282.
21. Puhan MA, Chandra D, Mosenifar Z, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011;37:784-790.
22. Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, Schunemann HJ. Interpretation of treatment changes in 6-min-ute walk distance in patients with COPD. Eur Respir J. 2008;32:637-643.
23. Dolmage TE, Hill K, Evans RA, Goldstein RS. Has my patient responded? Interpreting clinical measurements such as the Six Minute Walk Test. Am J Respir Crit Care Med. 2011;184:642-646.
24. McKenzie DK, Abramson M, Crockett AJ, et al. The COPD-X plan:Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease. http://www. copdx.org.au/. Published 2007. Accessed June 2008.
25. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511-522
26. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement:guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med. 2002;166:111-117.
27. Celli BR, Cote CG, Marin JM, et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-1012.
28. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease:A population based cohort study. Thorax. 2006;61:772-778.
29. Quint JK, Donaldson GC, Hurst JR, Goldring JJ, Seemungal TR, Wedzicha JA. Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur Respir J. 2011;37:501-507.
30. ZuWallack R, Hashim A, McCusker C, Normandin E, Benoit-Connors ML, Lahiri B. The trajectory of change over multiple outcome areas during comprehensive outpatient pulmonary rehabilitation. Chron Respir Dis. 2006;3:11-18.
31. Rossi G, Florini F, Romagnoli M, et al. Length and clinical effectiveness of pulmonary rehabilitation in outpatients with chronic airway obstruction. Chest. 2005;127:105-109.
32. Alison J, Barrack C, Cafarella P, et al. The Pulmonary Rehabilitation Toolkit on behalf of The Australian Lung Foundation. http://www.pulmonaryrehab. com.au/welcome.asp. Published 2009. Accessed May 2012.
33. Alison JA, Anderson SD. Comparison of two methods of assessing physical performance in patients with chronic airway obstruction. Phys Ther. 1981;61:1278-1280.
34. Puhan M, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2009;(1):CD005305.
35. Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K. Risk factors for the metabolic syndrome:The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care. 2004;27:2707-2715.
36. McNamara RJ, Alison JA, McKeough ZJ. Water-based exercise in chronic obstructive pulmonary disease. Phys Ther Rev. 2011;16:25-30.
37. Baltzan MA, Kamel H, Alter A, Rotaple M, Wolkove N. Pulmonary rehabilitation improves functional capacity in patients 80 years of age or older. Can Respir J. 2004;11:407-413.
38. Couser JI Jr, Guthmann R, Hamadeh MA, Kane CS. Pulmonary rehabilitation improves exercise capacity in older elderly patients with COPD. Chest. 1995;107:730-734.
39. Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:19-38.
40. Burtin C, Saey D, Saglam M, et al. Effectiveness of exercise training in patients with COPD:The role of muscle fatigue. Eur Respir J. 2012;40:338-344.